---
type: "Evidence Item"
title: "Introducing GPT-Rosalind for life sciences research"
description: "OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows."
resource: "https://openai.com/index/introducing-gpt-rosalind"
tags: ["appendix-iii", "benchmark", "openai"]
timestamp: "2026-04-16"
category: "benchmark"
publisher: "OpenAI"
cope_score: 86
confidence: 0.9
---

# Introducing GPT-Rosalind for life sciences research

# Claim

OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.

# Relevance

Appendix III, section one: model and benchmark capability evidence

# Oracle Verdict

OpenAI is describing a frontier or production capability that pushes directly on the thesis. The important signal is not the marketing language; it is the widening set of tasks now being routed through model-driven execution rather than ordinary software or headcount.

# Metadata

* Publisher: OpenAI
* Category: benchmark
* Sector: Healthcare and life sciences
* Capability: Frontier model release and benchmark movement
* Cope score: 86
* Confidence: 0.9

# Related Concepts

* [Live evidence index](index.md)
* [Thesis](../thesis.md)

# Citations

[1] [Introducing GPT-Rosalind for life sciences research](https://openai.com/index/introducing-gpt-rosalind)